Company – Scrape Financial

Insider Buys

This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Summary

Risk Factors Update Summary

  • The company now highlights risks from cash held in excess of $250,000 at banks. This change might result in potential losses if banks fail.
  • The competitive landscape for RSV and immunology diseases has intensified, with many companies developing therapies. This could impact market share and revenue.
  • The proposed BIOSECURE Act could restrict partnerships with certain Chinese biotech companies, affecting operations and funding opportunities. This change may lead to significant operational challenges.

Full Text Changes in Most Recent 10-K

Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.

To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1177648&owner=exclude

Click here to download the PDF

This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.